Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04349514 · ClinicalTrials.gov registry record
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA)
A clinical trial of Friedreich Ataxia, sponsored by Monash University.
- Active
- Registry status
- 300
- Enrollment target
- 7
- Study locations
NCT04349514 is a study of Friedreich Ataxia that is active but no longer recruiting, run by Monash University. The registered enrollment target is 300 participants, below the 428-participant average among 14 other Friedreich Ataxia trials with a reported enrollment target (30% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT04349514, a study of Friedreich Ataxia, is active but no longer recruiting, sponsored by Monash University.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a natural history study prospectively investigating neuroimaging markers of disease progression in children and adults with Friedreich ataxia (FA). There will be three assessment periods (baseline, 12 and 24 months). The study will include approximately 200 individuals with FA and 100 matched controls recruited across the six international academic sites. Other assessments will include secondary clinical and cognitive markers, as well as exploratory blood markers.
Conditions Studied
Interventions
- OTHER Natural history
Study Locations (7)
Florida
- University of Florida - Gainesville
Minnesota
- Center for Magnetic Resonance Research, University of Minnesota - Minneapolis
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Victoria
- Monash Biomedical Imaging, Monash University - Clayton
São Paulo
- Lab of Neuroimaging and Dept of Neurology, University of Campinas (UNICAMP) - São Paulo
Quebec
- McGill University - Montreal
Other
- Department of Neurology, RWTH Aachen University - Aachen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2025-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04349514
The ClinicalTrials.gov registry entry for NCT04349514 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 428-participant average among 14 other Friedreich Ataxia trials with a reported enrollment target (30% lower). The listed sponsor is Monash University, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Friedreich Ataxia appearing as the primary indexed condition, and to 1 intervention - of which Natural history is the first listed.
NCT04349514 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Florida, Minnesota, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04349514 about?
NCT04349514 is a clinical study titled "A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA)". This is a natural history study prospectively investigating neuroimaging markers of disease progression in children and adults with Friedreich ataxia (FA). There will be three assessment periods (baseline, 12 and 24 months). The study will include approximately 200 individuals with FA and 100 matche...
What is the current status of trial NCT04349514?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2021-02-10. Estimated completion is 2025-10.
What conditions does trial NCT04349514 study?
This clinical trial studies the following conditions: Friedreich Ataxia.
What interventions are being tested in trial NCT04349514?
The interventions under investigation include: Natural history (OTHER).
Who is sponsoring clinical trial NCT04349514?
This trial is sponsored by Monash University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04349514 being conducted?
This trial has 7 study locations across Florida, Minnesota, Pennsylvania, Victoria, São Paulo. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Friedreich Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Course Of Disease In Participants With FA-CM
RECRUITING
-
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
RECRUITING
-
A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
RECRUITING · Phase 1
-
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
RECRUITING · Phase 1
-
A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
RECRUITING
-
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.